Pharma Deals Review, Vol 2007, No 89 (2007)

Font Size:  Small  Medium  Large

Shire Divests Non-Essential Products

Business Review Editor

Abstract


Shire has agreed to sell a portfolio of non-core dermatology and other products with part of their associated sales network in Europe to Almirall for US$213 M in cash.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.